Prostatic Neoplasms: all 6,484 studies
Page 27 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Active, not recruitingNCT07214961Phase 1
- 68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRICompletedNCT07209865Phase 2
- Surveillance or Focal TherapyActive, not recruitingNCT07207902Not applicable
- Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial EmulationCompletedNCT07206693
- Quality of Life, Functional and Cognitive Outcomes in Patients With Metastatic Hormone-Sensitive Prostate CancerCompletedNCT07181122
- A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate CancerActive, not recruitingNCT07174063Phase 1
- The Impact of Video Education on Pain and Anxiety in Patients Undergoing Transrectal Ultrasonography-Guided Prostate BiopsyCompletedNCT07156747Not applicable
- Long-term Outcomes of Prostate Cancer ScreeningActive, not recruitingNCT07155759Not applicable
- Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian FederationSuspendedNCT07146113
- Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy SpecimenCompletedNCT07141121Not applicable
- Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.CompletedNCT07134504
- The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer PatientsActive, not recruitingNCT07126860Not applicable
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
- Phase 2 Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT07117760Phase 2
- Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)SuspendedNCT07102212Not applicable
- Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical ProstatectomyCompletedNCT07101731Not applicable
- Periprostatic Neurolysis in Prostate CancerActive, not recruitingNCT07100847Phase 1
- A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)CompletedNCT07086651
- AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP）Active, not recruitingNCT07082049Not applicable
- Acceptability of Artificial Intelligence in the Diagnosis of Prostate CancerCompletedNCT07074405Not applicable
- Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy StagingCompletedNCT07069465Early Phase 1
- PSMA PET Combined With MRI for the Detection of PCaActive, not recruitingNCT07052214Phase 3
- Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic GroupsActive, not recruitingNCT07048613
- A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)Active, not recruitingNCT07047118Phase 2
- A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsActive, not recruitingNCT07038369Phase 1
- Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging of Prostate CancerCompletedNCT07024030Phase 2
- A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy SubjectsCompletedNCT07014488Phase 1
- Effects of Music and Conversation in Prostate BiopsyCompletedNCT07006779Not applicable
- The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication Development in Transrectal Ultrasonography Guided Prostate BiopsyCompletedNCT06998121Not applicable
- Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION TrialActive, not recruitingNCT06995053Not applicable
- Efficacy Of Acupuncture in Pain and Anxiety During Transperineal Prostate Biopsy: A Prospective, Randomized, Sham-Controlled TrialCompletedNCT06987071Not applicable
- Stratagen Quantitative Prostate MRI Platform Pilot StudyActive, not recruitingNCT06985238Not applicable
- Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO QuestionnaireActive, not recruitingNCT06985004
- The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.CompletedNCT06984159Phase 3
- Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to BonesWithdrawnNCT06982222Phase 1
- 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate CancerActive, not recruitingNCT06970847Phase 3
- The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate BrachytherapyActive, not recruitingNCT06964412Not applicable
- Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.CompletedNCT06955910
- Hypofractionation for Prostate Cancer in Africa: A Feasibility StudyActive, not recruitingNCT06950307
- European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer DetectionActive, not recruitingNCT06935487Not applicable
- Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real-World StudyActive, not recruitingNCT06929884
- Randomized Trial of HIFU vs. Cryo for Prostate CancerCompletedNCT06929065Not applicable
- Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate CancerCompletedNCT06919159
- The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate CancerCompletedNCT06915714
- Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation TherapyActive, not recruitingNCT06908694Phase 4
- Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical ProstatectomyCompletedNCT06907641Phase 2
- A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NSActive, not recruitingNCT06906471Phase 1/2
- Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims DatabaseCompletedNCT06902441
- Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPCActive, not recruitingNCT06895811Phase 1
- Feasibility of Day-surgery Management for Patients Undergoing Robotic Radical Prostatectomy: a Randomized TrialActive, not recruitingNCT06891664Not applicable
- Osteosclerotic Changes on CT Predict Survival in Prostate CancerCompletedNCT06883474
- Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPCWithdrawnNCT06881823Phase 1/2
- Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT06866548Early Phase 1
- ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by ApalutamideActive, not recruitingNCT06865547
- Analysis of Immediate Urinary Continence Predictors After RS-RARPActive, not recruitingNCT06850116
- A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate CancerCompletedNCT06840535Phase 1
- Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate CancerCompletedNCT06837896Phase 3
- Prostate Hyperfixation on PET-choline in Patients With Prostate Cancer: Correlation With MRI and Pathological Data (LOC-CHOLINE)CompletedNCT06836154
- Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate CancerCompletedNCT06827340
- The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate CancerActive, not recruitingNCT06824259Not applicable
- Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen ResponseActive, not recruitingNCT06822491
- Comprehensive Assessment of Cancer Theranostic ResponseActive, not recruitingNCT06815354Not applicable
- Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate CancerCompletedNCT06809426Not applicable
- Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate CancerCompletedNCT06807398
- Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)WithdrawnNCT06804785
- Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate CancerWithdrawnNCT06795191Phase 3
- Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate CancerWithdrawnNCT06795178Phase 3
- Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3DCompletedNCT06783088
- Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsActive, not recruitingNCT06781983Phase 1
- Genetic Studies of Prostate Cancer Aggressiveness and PrognosisCompletedNCT06773858
- Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.WithdrawnNCT06765954Phase 2
- Immunotherapy Before and After SurgeryWithdrawnNCT06765902Phase 2
- Exploring Men s Prostate Cancer Genetic Risk PerceptionsCompletedNCT06764992
- A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT06764485Phase 3
- Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerCompletedNCT06754085Phase 3
- Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate CancerActive, not recruitingNCT06734130Phase 2
- A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.Active, not recruitingNCT06733337
- Investigation of the Diagnostic Role of miRNAs in PCa and BPHCompletedNCT06726070
- Genetics of Prostate Cancer in Young PatientsCompletedNCT06714227
- InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer SurvivorsCompletedNCT06703996Not applicable
- Long Acting Neuraxial Peri-prostatic Block in CancerActive, not recruitingNCT06703437Phase 1
- Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)Active, not recruitingNCT06691984Phase 3
- Effect of Education to be Provided to Patients to Undergo TURP With Mobile Application on Patient OutcomesCompletedNCT06687538Not applicable
- A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical ProstatectomyActive, not recruitingNCT06671782Not applicable
- Suturing Techniques for Vesico-urethral AnastomosisCompletedNCT06670924Not applicable
- Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN TrialCompletedNCT06661902Phase 1/2
- Understanding the Benefits of Dietary Fibre Supplementation in Patients With Prostate CancerCompletedNCT06661044
- Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging EvaluationsTerminatedNCT06655064
- WATER IV Prostate CancerActive, not recruitingNCT06651632Not applicable
- Elimination of Prostate Cancer Treatment Side Effects Using a NutraceuticalSuspendedNCT06643494Phase 1/2
- Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane AntigenCompletedNCT06641219Phase 1
- COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerActive, not recruitingNCT06627530Phase 4
- Evaluation of an Online Prostate Cancer Screening Decision AidCompletedNCT06610474Not applicable
- Otago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation TherapyCompletedNCT06605846Not applicable
- Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image FeaturesCompletedNCT06604377
- The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer PatientsCompletedNCT06604247Not applicable
- Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.CompletedNCT06601205Phase 2/3
- Rectal Spacers in Prostate Cancer Patients Undergoing Radiation TherapyActive, not recruitingNCT06599476Not applicable
- Rectal Spacers Use in Prostate Cancer Radiation TherapyActive, not recruitingNCT06594887Not applicable
- The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis AnalysisCompletedNCT06589154